Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
43.51
-0.54 (-1.23%)
Nov 21, 2024, 4:00 PM EST - Market closed
Kymera Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -167.47 | -146.96 | -154.81 | -100.22 | -45.59 | -41.25 | Upgrade
|
| Depreciation & Amortization | 6.28 | 3.57 | 2.98 | 2.4 | 1.76 | 0.83 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.02 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.33 | 0.44 | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.99 | -5.23 | 0.89 | 5.81 | 1.57 | - | Upgrade
|
| Stock-Based Compensation | 52.11 | 43.12 | 35.48 | 24.97 | 5.19 | 1.2 | Upgrade
|
| Change in Accounts Receivable | 2.46 | -16.23 | -2.4 | 1.3 | -1.43 | - | Upgrade
|
| Change in Accounts Payable | 1.73 | 2.04 | 0.25 | 0.05 | 0.99 | 0.9 | Upgrade
|
| Change in Unearned Revenue | -23.75 | -8.61 | -37.77 | -69.36 | 117.4 | 52.99 | Upgrade
|
| Change in Other Net Operating Assets | 11.03 | 25.48 | 2.3 | 6.08 | 7.91 | 2.79 | Upgrade
|
| Operating Cash Flow | -124.67 | -102.83 | -153.09 | -128.95 | 88.13 | 17.91 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 392.21% | - | Upgrade
|
| Capital Expenditures | -23.53 | -34.48 | -2.84 | -1.6 | -9.1 | -0.53 | Upgrade
|
| Investment in Securities | -430.17 | 174.37 | 23.36 | -98.24 | -413.49 | -15.95 | Upgrade
|
| Investing Cash Flow | -453.69 | 139.89 | 20.52 | -99.84 | -422.59 | -16.49 | Upgrade
|
| Long-Term Debt Repaid | - | -0.08 | -1.13 | -0.85 | -0.55 | -0.37 | Upgrade
|
| Net Debt Issued (Repaid) | -0.36 | -0.08 | -1.13 | -0.85 | -0.55 | -0.37 | Upgrade
|
| Issuance of Common Stock | 608.38 | 4.27 | 154.13 | 251.53 | 196.84 | 0.07 | Upgrade
|
| Other Financing Activities | - | - | - | -0.4 | - | - | Upgrade
|
| Financing Cash Flow | 608.02 | 4.19 | 153 | 250.28 | 289.26 | 34.91 | Upgrade
|
| Net Cash Flow | 29.66 | 41.25 | 20.43 | 21.5 | -45.2 | 36.33 | Upgrade
|
| Free Cash Flow | -148.2 | -137.31 | -155.92 | -130.54 | 79.03 | 17.37 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 354.92% | - | Upgrade
|
| Free Cash Flow Margin | -169.25% | -174.71% | -332.98% | -179.24% | 232.22% | 592.13% | Upgrade
|
| Free Cash Flow Per Share | -2.13 | -2.35 | -2.89 | -2.72 | 4.56 | 10.23 | Upgrade
|
| Cash Interest Paid | 0.19 | 0.16 | 0.18 | 0.16 | 0.12 | 0.05 | Upgrade
|
| Levered Free Cash Flow | -94.1 | -97.62 | -90.21 | -58.3 | 39.76 | 1.53 | Upgrade
|
| Unlevered Free Cash Flow | -93.95 | -97.49 | -90.1 | -58.19 | 39.83 | 1.56 | Upgrade
|
| Change in Net Working Capital | 6.77 | 6.24 | 24.94 | 21.13 | -70.91 | -26.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.